Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00253708
Official study title

Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer

Study summary

RATIONALE: Massage therapy may help relieve symptoms associated with cancer. It is not yet known which type of massage therapy is more effective in treating the symptoms of patients with cancer. PURPOSE: This randomized clinical trial is studying different types of massage therapy to compare how well they work in treating the symptoms of patients with locally advanced or metastatic cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedmanagement of therapy complications and massage therapy

Plus 3 other study approaches.

Who it may be forLocally advanced · Metastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 7, 2017 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Beth Israel Deaconess Medical Center

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Beth Israel Deaconess Medical Center
Interventions being studied
Procedure: management of therapy complications; Procedure: massage therapy; Procedure: pain therapy; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Locally advanced→Metastatic or stage IV→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Solid cancer with evidence of metastases
  • Receiving treatment at Beth Israel Deaconess Medical Center (BIDMC)
  • Must reside ≤ 25 miles from BIDMC
Reasons someone may not be able to joinExclusion criteria
  • Patient to sick to be interviewed
  • Absence of severe symptoms
  • Participating in another trial
  • Language barrier
  • MD does not provide permission
  • Expired prior to consent process

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Beth Israel Deaconess Medical CenterBoston, Massachusetts

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 7, 2017. Always confirm current availability with the study team.

View original record ↗